Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
iScience ; 24(11): 103221, 2021 Nov 19.
Article in English | MEDLINE | ID: mdl-34746695

ABSTRACT

Neurodegenerative diseases are challenging for systems biology because of the lack of reliable animal models or patient samples at early disease stages. Induced pluripotent stem cells (iPSCs) could address these challenges. We investigated DNA, RNA, epigenetics, and proteins in iPSC-derived motor neurons from patients with ALS carrying hexanucleotide expansions in C9ORF72. Using integrative computational methods combining all omics datasets, we identified novel and known dysregulated pathways. We used a C9ORF72 Drosophila model to distinguish pathways contributing to disease phenotypes from compensatory ones and confirmed alterations in some pathways in postmortem spinal cord tissue of patients with ALS. A different differentiation protocol was used to derive a separate set of C9ORF72 and control motor neurons. Many individual -omics differed by protocol, but some core dysregulated pathways were consistent. This strategy of analyzing patient-specific neurons provides disease-related outcomes with small numbers of heterogeneous lines and reduces variation from single-omics to elucidate network-based signatures.

2.
Am Surg ; 86(9): 1208-1211, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32683914

ABSTRACT

Atypical spindle cell lipomatous neoplasm, also known as well-differentiated spindle cell liposarcoma, represents a newly discovered entity of adipocytic tumors. Recent research has shown this tumor variant to be more related to spindle cell lipoma, rather than the originally hypothesized atypical lipomatous tumor spectrum. Here we present a case of a 58-year-old man with a history of chronic lymphocytic leukemia with an enlarging mass on the posterior left shoulder, initially hypothesized to be a benign lipoma. However, magnetic resonance imaging showed a large, multiseptated, heterogeneous mass concerning for soft tissue sarcoma. After resection, pathologic analysis showed cells closely resembling spindle cell lipoma, with additional cellular and fascicular zones containing lipoblasts and mitotic figures. Molecular analysis showed no MDM2 amplification. This lack of amplification indicates this tumor is distinctly different from an atypical lipomatous tumor, which characteristically displays MDM2 amplification. However, tumor expression of RB1 was normal. The majority of atypical spindle cell lipomatous neoplasms are associated with RB1 deletions. We conclude that we have a unique example of an atypical spindle cell lipomatous tumor.


Subject(s)
Dermatologic Surgical Procedures/methods , Leukemia, Lymphocytic, Chronic, B-Cell/complications , Liposarcoma/surgery , Skin Neoplasms/surgery , Biopsy , Diagnosis, Differential , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis , Liposarcoma/diagnosis , Male , Middle Aged , Skin Neoplasms/diagnosis
3.
Nat Neurosci ; 22(5): 741-752, 2019 05.
Article in English | MEDLINE | ID: mdl-30936556

ABSTRACT

Despite expanding knowledge regarding the role of astroglia in regulating neuronal function, little is known about regional or functional subgroups of brain astroglia and how they may interact with neurons. We use an astroglia-specific promoter fragment in transgenic mice to identify an anatomically defined subset of adult gray matter astroglia. Using transcriptomic and histological analyses, we generate a combinatorial profile for the in vivo identification and characterization of this astroglia subpopulation. These astroglia are enriched in mouse cortical layer V; express distinct molecular markers, including Norrin and leucine-rich repeat-containing G-protein-coupled receptor 6 (LGR6), with corresponding layer-specific neuronal ligands; are found in the human cortex; and modulate neuronal activity. Astrocytic Norrin appears to regulate dendrites and spines; its loss, as occurring in Norrie disease, contributes to cortical dendritic spine loss. These studies provide evidence that human and rodent astroglia subtypes are regionally and functionally distinct, can regulate local neuronal dendrite and synaptic spine development, and contribute to disease.


Subject(s)
Astrocytes/metabolism , Cerebral Cortex/metabolism , Eye Proteins/metabolism , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Animals , Cells, Cultured , Dendritic Spines/physiology , Gray Matter/metabolism , Humans , Male , Mice, Inbred C57BL , Mice, Transgenic , Motor Cortex/metabolism , Receptors, G-Protein-Coupled/metabolism , Transcriptome
5.
Neuron ; 99(5): 925-940.e7, 2018 09 05.
Article in English | MEDLINE | ID: mdl-30189209

ABSTRACT

Tau is the major constituent of neurofibrillary tangles in Alzheimer's disease (AD), but the mechanism underlying tau-associated neural damage remains unclear. Here, we show that tau can directly interact with nucleoporins of the nuclear pore complex (NPC) and affect their structural and functional integrity. Pathological tau impairs nuclear import and export in tau-overexpressing transgenic mice and in human AD brain tissue. Furthermore, the nucleoporin Nup98 accumulates in the cell bodies of some tangle-bearing neurons and can facilitate tau aggregation in vitro. These data support the hypothesis that tau can directly interact with NPC components, leading to their mislocalization and consequent disruption of NPC function. This raises the possibility that NPC dysfunction contributes to tau-induced neurotoxicity in AD and tauopathies.


Subject(s)
Alzheimer Disease/metabolism , Cell Nucleus/metabolism , Cytoplasm/metabolism , tau Proteins/metabolism , Active Transport, Cell Nucleus/physiology , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Animals , Cell Nucleus/pathology , Cytoplasm/pathology , Female , Humans , Male , Mice , Mice, Transgenic
6.
Cell ; 173(4): 958-971.e17, 2018 05 03.
Article in English | MEDLINE | ID: mdl-29628143

ABSTRACT

Defects in nucleocytoplasmic transport have been identified as a key pathogenic event in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) mediated by a GGGGCC hexanucleotide repeat expansion in C9ORF72, the most common genetic cause of ALS/FTD. Furthermore, nucleocytoplasmic transport disruption has also been implicated in other neurodegenerative diseases with protein aggregation, suggesting a shared mechanism by which protein stress disrupts nucleocytoplasmic transport. Here, we show that cellular stress disrupts nucleocytoplasmic transport by localizing critical nucleocytoplasmic transport factors into stress granules, RNA/protein complexes that play a crucial role in ALS pathogenesis. Importantly, inhibiting stress granule assembly, such as by knocking down Ataxin-2, suppresses nucleocytoplasmic transport defects as well as neurodegeneration in C9ORF72-mediated ALS/FTD. Our findings identify a link between stress granule assembly and nucleocytoplasmic transport, two fundamental cellular processes implicated in the pathogenesis of C9ORF72-mediated ALS/FTD and other neurodegenerative diseases.


Subject(s)
Active Transport, Cell Nucleus/physiology , Amyotrophic Lateral Sclerosis/pathology , Ataxin-2/metabolism , C9orf72 Protein/genetics , Frontotemporal Dementia/pathology , Active Transport, Cell Nucleus/drug effects , Aged , Amyotrophic Lateral Sclerosis/metabolism , Arsenites/toxicity , Ataxin-2/antagonists & inhibitors , Ataxin-2/genetics , C9orf72 Protein/metabolism , DNA Repeat Expansion/genetics , Female , Frontotemporal Dementia/metabolism , HEK293 Cells , Humans , Male , Membrane Glycoproteins/metabolism , Middle Aged , Nuclear Pore Complex Proteins/metabolism , Oxidative Stress/drug effects , RNA Interference , RNA, Small Interfering/metabolism , Sodium Compounds/toxicity , alpha Karyopherins/antagonists & inhibitors , alpha Karyopherins/genetics , alpha Karyopherins/metabolism , beta Karyopherins/antagonists & inhibitors , beta Karyopherins/genetics , beta Karyopherins/metabolism , ran GTP-Binding Protein/antagonists & inhibitors , ran GTP-Binding Protein/genetics , ran GTP-Binding Protein/metabolism
7.
Neuron ; 94(1): 93-107.e6, 2017 Apr 05.
Article in English | MEDLINE | ID: mdl-28384479

ABSTRACT

Huntington's disease (HD) is caused by an expanded CAG repeat in the Huntingtin (HTT) gene. The mechanism(s) by which mutant HTT (mHTT) causes disease is unclear. Nucleocytoplasmic transport, the trafficking of macromolecules between the nucleus and cytoplasm, is tightly regulated by nuclear pore complexes (NPCs) made up of nucleoporins (NUPs). Previous studies offered clues that mHTT may disrupt nucleocytoplasmic transport and a mutation of an NUP can cause HD-like pathology. Therefore, we evaluated the NPC and nucleocytoplasmic transport in multiple models of HD, including mouse and fly models, neurons transfected with mHTT, HD iPSC-derived neurons, and human HD brain regions. These studies revealed severe mislocalization and aggregation of NUPs and defective nucleocytoplasmic transport. HD repeat-associated non-ATG (RAN) translation proteins also disrupted nucleocytoplasmic transport. Additionally, overexpression of NUPs and treatment with drugs that prevent aberrant NUP biology also mitigated this transport defect and neurotoxicity, providing future novel therapy targets.


Subject(s)
Active Transport, Cell Nucleus/genetics , Huntingtin Protein/genetics , Huntington Disease/genetics , Nuclear Pore Complex Proteins/metabolism , Nuclear Pore/metabolism , Adult , Animals , Disease Models, Animal , Drosophila , Drosophila Proteins , Female , Humans , Induced Pluripotent Stem Cells , Male , Mice , Middle Aged , Mutation , Young Adult
8.
Acta Neuropathol ; 131(4): 605-20, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26728149

ABSTRACT

Amyotrophic lateral sclerosis is characterized by progressive loss of motor neurons in the brain and spinal cord. Mutations in several genes, including FUS, TDP43, Matrin 3, hnRNPA2 and other RNA-binding proteins, have been linked to ALS pathology. Recently, Pur-alpha, a DNA/RNA-binding protein was found to bind to C9orf72 repeat expansions and could possibly play a role in the pathogenesis of ALS. When overexpressed, Pur-alpha mitigates toxicities associated with Fragile X tumor ataxia syndrome (FXTAS) and C9orf72 repeat expansion diseases in Drosophila and mammalian cell culture models. However, the function of Pur-alpha in regulating ALS pathogenesis has not been fully understood. We identified Pur-alpha as a novel component of cytoplasmic stress granules (SGs) in ALS patient cells carrying disease-causing mutations in FUS. When cells were challenged with stress, we observed that Pur-alpha co-localized with mutant FUS in ALS patient cells and became trapped in constitutive SGs. We also found that FUS physically interacted with Pur-alpha in mammalian neuronal cells. Interestingly, shRNA-mediated knock down of endogenous Pur-alpha significantly reduced formation of cytoplasmic stress granules in mammalian cells suggesting that Pur-alpha is essential for the formation of SGs. Furthermore, ectopic expression of Pur-alpha blocked cytoplasmic mislocalization of mutant FUS and strongly suppressed toxicity associated with mutant FUS expression in primary motor neurons. Our data emphasizes the importance of stress granules in ALS pathogenesis and identifies Pur-alpha as a novel regulator of SG dynamics.


Subject(s)
Cytoplasmic Granules/metabolism , DNA-Binding Proteins/metabolism , Gene Expression Regulation/genetics , Motor Neurons/metabolism , RNA-Binding Protein FUS/metabolism , Transcription Factors/metabolism , Amyotrophic Lateral Sclerosis/pathology , Animals , Anti-Bacterial Agents/pharmacology , Arsenites/pharmacology , Brain/cytology , Carrier Proteins/metabolism , Cells, Cultured , Cytoplasmic Granules/drug effects , DNA Helicases , DNA-Binding Proteins/genetics , Doxycycline/pharmacology , Embryo, Mammalian , Enzyme Inhibitors/pharmacology , Female , Gene Expression Regulation/drug effects , Humans , Male , Microtubule-Associated Proteins/metabolism , Poly-ADP-Ribose Binding Proteins , RNA Helicases , RNA Recognition Motif Proteins , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , RNA-Binding Protein FUS/genetics , Rats , Rats, Sprague-Dawley , Sodium Compounds/pharmacology , Transcription Factors/genetics
9.
Curr Oncol ; 22(6): e485-92, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26715887

ABSTRACT

BACKGROUND: We estimated the relations of sociodemographic, organizational, disease, and treatment variables with the risk of death from colorectal cancer (crc) in a Quebec population-based sample of patients with locally advanced crc (lacrc) who underwent tumour resection with curative intent. METHODS: Information from medical records and administrative databases was obtained for a random sample of 633 patients surgically treated for stages ii-iii rectal and stage iii colon cancer and declared to the Quebec cancer registry in 1998 and 2003. We measured personal, disease, and clinical management characteristics, relative survival, and through multivariate modelling, relative excess rate (rer) of death. RESULTS: The relative 5- and 10-year survivals in this cohort were 67.7% [95% confidence interval (ci): 65.8% to 69.6%] and 61.2% (95% ci: 58.3% to 64.0%) respectively. Stage T4, stage N2, and emergency rather than elective surgery affected 18%, 24% and 10% of patients respectively. Those disease progression characteristics each independently increased the rer of death by factors of 2 to almost 5. Grade, vascular invasion, and tumour location were also significantly associated with the rer for death. Receiving guideline-adherent treatment was associated with a 60% reduction in the rer for death (0.41; 95% ci: 0.28 to 0.61), an effect that was consistent across age groups. Clear margins (proximal-distal, radial) and clinical trial enrolment were each associated with a nonsignificant 50% reduction in the rer. Of patients less than 70 years of age and 70 years of age and older, 81.3% and 42.0% respectively received guideline-adherent treatment. CONCLUSIONS: This study is the first Quebec population-based examination of patients with lacrc and their management, outcomes, and outcome determinants. The results can help in planning crc control strategies at a population level.

10.
Cell Metab ; 20(1): 145-57, 2014 Jul 01.
Article in English | MEDLINE | ID: mdl-24882066

ABSTRACT

Neurodegenerative diseases represent an increasing burden in our aging society, yet the underlying metabolic factors influencing onset and progression remain poorly defined. The relationship between impaired IGF-1/insulin-like signaling (IIS) and lifespan extension represents an opportunity to investigate the interface of metabolism with age-associated neurodegeneration. Using data sets of established DAF-2/IIS-signaling components in Caenorhabditis elegans, we conducted systematic RNAi screens in worms to select for daf-2-associated genetic modifiers of α-synuclein misfolding and dopaminergic neurodegeneration, two clinical hallmarks of Parkinson's disease. An outcome of this strategy was the identification of GPI-1/GPI, an enzyme in glucose metabolism, as a daf-2-regulated modifier that acts independent of the downstream cytoprotective transcription factor DAF-16/FOXO to modulate neuroprotection. Subsequent mechanistic analyses using Drosophila and mouse primary neuron cultures further validated the conserved nature of GPI neuroprotection from α-synuclein proteotoxicity. Collectively, these results support glucose metabolism as a conserved functional node at the intersection of proteostasis and neurodegeneration.


Subject(s)
Dopaminergic Neurons/metabolism , Glucose-6-Phosphate Isomerase/metabolism , Aging , Animals , Caenorhabditis elegans/metabolism , Caenorhabditis elegans Proteins/antagonists & inhibitors , Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans Proteins/metabolism , Cells, Cultured , Cytokines/antagonists & inhibitors , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Dopaminergic Neurons/cytology , Drosophila/metabolism , Drosophila Proteins/antagonists & inhibitors , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Forkhead Transcription Factors/metabolism , Glucose/metabolism , Glucose-6-Phosphate Isomerase/antagonists & inhibitors , Glucose-6-Phosphate Isomerase/genetics , Glycolysis , Insulin Receptor Substrate Proteins/genetics , Insulin Receptor Substrate Proteins/metabolism , Insulin-Like Growth Factor I/metabolism , Male , Mice , Parkinson Disease/metabolism , Parkinson Disease/pathology , RNA Interference , RNA, Small Interfering/metabolism , Receptor, Insulin/antagonists & inhibitors , Receptor, Insulin/genetics , Receptor, Insulin/metabolism , Signal Transduction , Transcription Factors/antagonists & inhibitors , Transcription Factors/genetics , Transcription Factors/metabolism , alpha-Synuclein/chemistry , alpha-Synuclein/metabolism
11.
Hum Mol Genet ; 22(6): 1193-205, 2013 Mar 15.
Article in English | MEDLINE | ID: mdl-23257289

ABSTRACT

Amyotrophic lateral sclerosis (ALS) is an uncommon neurodegenerative disease caused by degeneration of upper and lower motor neurons. Several genes, including SOD1, TDP-43, FUS, Ubiquilin 2, C9orf72 and Profilin 1, have been linked with the sporadic and familiar forms of ALS. FUS is a DNA/RNA-binding protein (RBP) that forms cytoplasmic inclusions in ALS and frontotemporal lobular degeneration (FTLD) patients' brains and spinal cords. However, it is unknown whether the RNA-binding ability of FUS is required for causing ALS pathogenesis. Here, we exploited a Drosophila model of ALS and neuronal cell lines to elucidate the role of the RNA-binding ability of FUS in regulating FUS-mediated toxicity, cytoplasmic mislocalization and incorporation into stress granules (SGs). To determine the role of the RNA-binding ability of FUS in ALS, we mutated FUS RNA-binding sites (F305L, F341L, F359L, F368L) and generated RNA-binding-incompetent FUS mutants with and without ALS-causing mutations (R518K or R521C). We found that mutating the aforementioned four phenylalanine (F) amino acids to leucines (L) (4F-L) eliminates FUS RNA binding. We observed that these RNA-binding mutations block neurodegenerative phenotypes seen in the fly brains, eyes and motor neurons compared with the expression of RNA-binding-competent FUS carrying ALS-causing mutations. Interestingly, RNA-binding-deficient FUS strongly localized to the nucleus of Drosophila motor neurons and mammalian neuronal cells, whereas FUS carrying ALS-linked mutations was distributed to the nucleus and cytoplasm. Importantly, we determined that incorporation of mutant FUS into the SG compartment is dependent on the RNA-binding ability of FUS. In summary, we demonstrate that the RNA-binding ability of FUS is essential for the neurodegenerative phenotype in vivo of mutant FUS (either through direct contact with RNA or through interactions with other RBPs).


Subject(s)
Amyotrophic Lateral Sclerosis/metabolism , Cytoplasm/metabolism , Inclusion Bodies/metabolism , Mutation, Missense , RNA-Binding Protein FUS/metabolism , Amino Acid Motifs , Amyotrophic Lateral Sclerosis/genetics , Animals , Cell Nucleus/genetics , Cell Nucleus/metabolism , Cytoplasm/genetics , Disease Models, Animal , Drosophila/genetics , Drosophila/metabolism , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Heterogeneous-Nuclear Ribonucleoprotein Group F-H/genetics , Heterogeneous-Nuclear Ribonucleoprotein Group F-H/metabolism , Humans , Inclusion Bodies/genetics , Motor Neurons/metabolism , Protein Transport , RNA-Binding Protein FUS/chemistry , RNA-Binding Protein FUS/genetics
12.
Opt Express ; 20(6): 6825-34, 2012 Mar 12.
Article in English | MEDLINE | ID: mdl-22418565

ABSTRACT

Remote terahertz (THz) generation from two-color filamentation is investigated as a function of the onset position of filaments. THz signals emitted by filaments produced at distances up to 55 m from the laser source were measured. However, from 9 m to 55 m, the THz signal decayed monotonically for increasing onset positions. With a simple calculation, the dominant factors associated to this decay were identified as group velocity mismatch of the two-color pulses and linear diffraction induced by focusing and propagating the second harmonic pulse.


Subject(s)
Lighting/instrumentation , Terahertz Radiation , Color , Computer-Aided Design , Equipment Design , Equipment Failure Analysis
13.
J Neurochem ; 119(6): 1294-305, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21985068

ABSTRACT

The highly reactive nature of dopamine renders dopaminergic neurons vulnerable to oxidative damage. We recently demonstrated that loss-of-function mutations in the Drosophila gene Catecholamines up (Catsup) elevate dopamine pools but, paradoxically, also confer resistance to paraquat, an herbicide that induces oxidative stress-mediated toxicity in dopaminergic neurons. We now report a novel association of the membrane protein, Catsup, with GTP cyclohydrolase rate-limiting enzyme for tetrahydrobiopterin (BH(4)) biosynthesis and tyrosine hydroxylase, rate-limiting enzyme for dopamine biosynthesis, which requires BH(4) as a cofactor. Loss-of-function Catsup mutations cause dominant hyperactivation of both enzymes. Elevated dopamine levels in Catsup mutants coincide with several distinct characteristics, including hypermobility, minimal basal levels of 3,4-dihydroxy-phenylacetic acid, an oxidative metabolite of dopamine, and resistance to the vesicular monoamine transporter inhibitor, reserpine, suggesting that excess dopamine is synaptically active and that Catsup functions in the regulation of synaptic vesicle loading and release of dopamine. We conclude that Catsup regulates and links the dopamine synthesis and transport networks.


Subject(s)
Dopamine/metabolism , Dopaminergic Neurons/metabolism , Drosophila Proteins/metabolism , Synapses/genetics , Administration, Oral , Animals , Animals, Genetically Modified , Antipsychotic Agents/administration & dosage , Dopamine Agents/administration & dosage , Drosophila , Drosophila Proteins/genetics , Electrochemistry , Female , GTP Cyclohydrolase/metabolism , Green Fluorescent Proteins/genetics , Herbicides/administration & dosage , Immunoprecipitation , Levodopa/administration & dosage , Locomotion/drug effects , Locomotion/physiology , Male , Monoiodotyrosine/administration & dosage , Paraquat/administration & dosage , Protein Transport/drug effects , Protein Transport/genetics , Reserpine/administration & dosage , Synapses/drug effects , Tyrosine 3-Monooxygenase/genetics , Vesicular Monoamine Transport Proteins/genetics
15.
Bioelectromagnetics ; 25(5): 369-73, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15197761

ABSTRACT

A portable meter has been developed for measuring low frequency currents that flow in the human body. Although the present version of the meter was specifically designed to measure 50/60 Hz "contact currents," the principles involved can be used with other low frequency body currents. Contact currents flow when the human body provides a conductive path between objects in the environment with different electrical potentials. The range of currents the meter detects is approximately 0.4-800 microA. This provides measurements of currents from the threshold of human perception (approximately 500 microA(RMS)) down to single microampere levels. The meter has a unique design, which utilizes the human subject's body impedance as the sensing element. Some of the advantages of this approach are high sensitivity, the ability to measure current flow in the majority of the body, and relative insensitivity to the current path connection points. Current measurement accuracy varies with the accuracy of the body impedance (resistance) measurement and different techniques can be used to obtain a desired level of accuracy. Techniques are available to achieve an estimated +/-20% accuracy.


Subject(s)
Electricity , Electrophysiology/instrumentation , Environmental Exposure , Magnetics , Adult , Electric Conductivity , Electric Impedance , Equipment Design , Humans , Male , Occupational Exposure
16.
Cancer Res ; 61(24): 8859-65, 2001 Dec 15.
Article in English | MEDLINE | ID: mdl-11751409

ABSTRACT

Late effects after radiotherapy for brain tumors can be severe and tend to limit the efficacy of this treatment modality. The mechanisms governing the development of late radiation-induced lesions in the brain are not clear, but they are preceded by cycles of molecular and cellular events including production of cytokines, one of which is tumor necrosis factor (TNF)-alpha. There is literature to support possible roles for TNF-alpha as a contributor to edema, gliosis, and demyelination in the brain, all of which are histopathologically associated with radiation-induced brain damage. We have examined the role of TNF-alpha signaling in the response to brain irradiation using TNFRp55- or TNFRp75-deficient and control mice. Mice lacking TNFRp75 exhibited increased early radiation-induced apoptosis in putative stem cell regions of the brain. At 1 month, they had decreased proliferative responses in the same regions, and by 3 months they were demonstrating dose-dependent seizures and other severe neurological abnormalities that were not seen in control or TNFRp55-/- mice. Seizure activity correlated with the onset of extensive demyelination, and by 6 months, levels of myelin basic protein in irradiated TNFRp75-/- mice were approximately 40% of those seen in the other two strains; the animals were moribund and had to be euthanized. These observations indicate that radiation-induced TNF-alpha, acting through TNFRp75, protects against the development of late complications of brain irradiation.


Subject(s)
Brain/radiation effects , Radiation Tolerance/physiology , Signal Transduction/radiation effects , Tumor Necrosis Factor-alpha/physiology , Animals , Antigens, CD/genetics , Antigens, CD/physiology , Apoptosis/radiation effects , Brain/metabolism , Brain/physiology , Cell Division/radiation effects , Demyelinating Diseases/etiology , Female , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myelin Sheath/metabolism , Radiation Injuries, Experimental/etiology , Radiation Injuries, Experimental/metabolism , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor/physiology , Receptors, Tumor Necrosis Factor, Type I , Receptors, Tumor Necrosis Factor, Type II , Seizures/etiology , Signal Transduction/physiology
17.
Am J Vet Res ; 62(7): 1046-50, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11453478

ABSTRACT

OBJECTIVE: To describe the pharmacokinetics of cyclosporine (CyA) in healthy dogs after oral administration alone or in combination with orally administered cimetidine. ANIMALS: 10 healthy adult Beagles. PROCEDURE: Dogs were randomly assigned to receive CyA alone or CyA in combination with cimetidine. After a washout period of 2 weeks, dogs then received the alternate treatment. The CyA plus cimetidine treatment required administration of cimetidine (15 mg/kg of body weight, PO, q 8 h) for 8 days and administration of CyA (5 mg/kg, PO, q 24 h) on days 6 through 8. The CyA treatment alone required administration of CyA (5 mg/kg, PO, q 24 h) for 3 days. On the third day of CyA administration during each treatment, blood samples were collected immediately before (time 0) and 0.5, 1, 1.5, 2, 2.5, 3, 5, 7, 9, 11, 13, 15, 21, and 24 hours after initiating CyA administration. RESULTS: Time until maximum CyA concentration was significantly longer for CyA in combination with cimetidine. Assessment of estimated pharmacokinetic variables revealed a significantly faster rate of change in the distribution phase for CyA in combination with cimetidine. Maximum CyA concentration differed significantly among dogs but did not differ significantly between treatments. CONCLUSIONS AND CLINICAL RELEVANCE: Analysis of our data suggests that cimetidine may affect absorption of orally administered CyA, but overall, it does not affect the pharmacokinetics of CyA. There is considerable variability in the maximum concentration of CyA among dogs, and monitoring of blood concentrations of CyA during treatment is advised.


Subject(s)
Cimetidine/pharmacology , Cyclosporine/pharmacokinetics , Dogs/metabolism , Histamine H2 Antagonists/pharmacology , Immunosuppressive Agents/pharmacokinetics , Animals , Area Under Curve , Cross-Over Studies , Cyclosporine/agonists , Cyclosporine/blood , Drug Interactions , Female , Half-Life , Immunosuppressive Agents/agonists , Immunosuppressive Agents/blood , Male , Random Allocation
18.
Clin Tech Small Anim Pract ; 16(4): 214-8, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11793874

ABSTRACT

Draining tracts and nodules in the dog and cat can present a diagnostic challenge to the veterinarian. A systematic approach and a complete list of differential diagnoses are needed to define the underlying disease, so that appropriate therapeutic management can be instituted and prognosis can be discussed with the owner. The purpose of this article is to review a complete list of differential diagnoses for draining tracts and nodules in the dog and cat, and discuss the appropriate diagnostic steps including cytology, biopsy and histopathology, culture and sensitivity, serology, and diagnostic imaging that are an important part of the work-up for draining tracts and nodules.


Subject(s)
Abscess/veterinary , Cat Diseases/pathology , Dog Diseases/pathology , Fistula/veterinary , Skin Diseases/veterinary , Abscess/pathology , Animals , Cats , Dogs , Fistula/pathology , Skin Diseases/pathology
19.
Bioelectromagnetics ; 21(7): 538-53, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11015118

ABSTRACT

Residential electrical wiring safety practices in the US result in the possibility of a small voltage (up to a few tenths of a volt) on appliance surfaces with respect to water pipes or other grounded surfaces. This "open circuit voltage" (V(OC)) will cause "contact current" to flow in a person who touches the appliance and completes an electrical circuit to ground. This paper presents data suggesting that contact current due to V(OC) is an exposure that may explain the reported associations of residential magnetic fields with childhood leukemia. Our analysis is based on a computer model of a 40 house (single-unit, detached dwelling) neighborhood with electrical service that is representative of US grounding practices. The analysis was motivated by recent research suggesting that the physical location of power lines in the backyard, in contrast to the street, may be relevant to a relationship of power lines with childhood leukemia. In the model, the highest magnetic field levels and V(OC)s were both associated with backyard lines, and the highest V(OC)s were also associated with long ground paths in the residence. Across the entire neighborhood, magnetic field exposure was highly correlated with V(OC) (r = 0.93). Dosimetric modeling indicates that, compared to a very high residential level of a uniform horizontal magnetic field (10 mu T) or a vertical electric field (100 V/m), a modest level of contact current (approximately 18 mu A) leads to considerably greater induced electric fields (> 1 mV/m) averaged across tissue, such as bone marrow and heart. The correlation of V(OC) with magnetic fields in the model, combined with the dose estimates, lead us to conclude that V(OC) is a potentially important exposure with respect to childhood leukemia risks associated with residential magnetic fields. These findings, nonetheless, may not apply to residential service used in several European countries or to the Scandinavian studies concerned with populations exposed to magnetic fields from overhead transmission lines.


Subject(s)
Electromagnetic Fields/adverse effects , Neoplasms, Radiation-Induced/etiology , Child , Humans , Leukemia, Radiation-Induced/epidemiology , Leukemia, Radiation-Induced/etiology , Models, Biological , Radiometry , Risk Factors , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL